SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-050435
Filing Date
2017-08-09
Accepted
2017-08-09 06:59:58
Documents
5
Period of Report
2017-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-19882_18k.htm 8-K 41649
2 EX-10.1 a17-19882_1ex10d1.htm EX-10.1 1114631
3 EX-99.1 a17-19882_1ex99d1.htm EX-99.1 318772
4 GRAPHIC g198821ki01i001.jpg GRAPHIC 2594
5 GRAPHIC g198821mm01i001.jpg GRAPHIC 4332
  Complete submission text file 0001104659-17-050435.txt   1486341
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 171016396
SIC: 2834 Pharmaceutical Preparations